The VA MDE Oligopoly — VES / Leidos QTC / OptumServe

VA Medical Disability Exam (MDE) market — surged dramatically by the 2022 PACT Act expansion of veterans' disability benefits coverage. Total ceiling: $13.2 billion IDIQ vehicle. Market shares: Leidos QTC Medical Services $5.1 billion (DOMINANT), Maximus VES $3.7 billion (~30.8%), UnitedHealthcare OptumServe $3.4 billion, Loyal Source (smaller).

Critical Engine connection — OptumServe is the federal-services subsidiary of UnitedHealth Group, which is also the parent of OptumRx (engine node — third-position PBM oligopoly member, 100M+ covered lives, ~22-23% market share). The engine had OptumRx but lacked the federal-services-subsidiary footprint. The OptumRx + OptumServe pairing demonstrates the same UnitedHealth corporate apex penetrating BOTH the pharmacy-benefit substrate AND the federal-services-throughput substrate.

Substitutability Friction 12-18 months — moderate, because four incumbents already exist on the IDIQ vehicle. Maximus Ventures is investing in human-in-the-loop AI startups specifically targeting VES's clinical-assessment workload for margin expansion against stagnant federal labor caps.